The HPV Testing and PAP Test Market is Anticipated to grow at a High CAGR of 12-15 % by 2027

Growing number of HPV cases has led to an increase in the number of cervical cancers worldwide, and rising awareness among people for cervical cancer prevention are the key factors driving the global HPV Testing and PAP Test market.
BRUSSELS - June 6, 2023 - PRLog -- Cervical cancer ( is a malignant tumor that begins in the cells of the cervix, the lowermost part of the uterus. Cervical cancer begins when the cells on its surface transform into precancerous cells. If not destroyed or removed, these abnormal cells may turn into cancer cells and spread in the cervix and surrounding areas. Cervical cancer screening encompasses HPV and PAP tests, which can identify early-stage HPV infection or pre-cancerous abnormalities. By timely treatment, the onset of cancer can be prevented.

Technological Advancements in HPV Testing and PAP Tests Drive the Market

Increasing demand for the development of technologically advanced screening tests for early detection of cervical and vaginal cancers is poised to drive the HPV testing and PAP test market

For instance,

§  In Feb 2023, BD (Becton, Dickinson and Company) announced that U.S. Food and Drug Administration (FDA) approved BD Onclarity™ HPV Assay to be used with the ThinPrep® Pap Test.

Rising Cases of Cervical Cancer Boosts HPV Testing and PAP Test Market

Rising prevalence of the number of cervical cancers, growing aging population and the development of advanced technological screening tests are the key factors driving the market. Public awareness campaigns initiated by the government and other organizations, improving health insurance coverage, and favorable reimbursement policies.
For instance,

§  Sansure Biotech approved by NMPA in Aug 2022 for marketing HPV DNA Diagnostic Kit (PCR-Fluorescence Probing), screening 18 high-risk and 5 low-risk genotypes for cervical cancer using fast nucleic acid release tech.

North America Accounts for the Largest Share of the Global Market

North America dominates HPV & PAP Test market due to rising cervical cancers, awareness programs, key players, and developed healthcare system. Asia-Pacific region to grow with highest CAGR, driven by tech advancements, free screenings, and strategic initiatives by organizations.

The key players operating in the market include Abbott Laboratories, F. Hoffmann-La Roche AG, Becton, Dickinson and Company, Quest Diagnostics, Hologic Inc., Femasys Inc., Arbor Vita Corporation, Seegene Inc. and Thermo Fischer Scientific Inc., among others.

Organic and Inorganic Growth Strategies Adopted by Players to Establish Their Foothold in the Market

§  In May 2022, the London School of Hygiene & Tropical Medicine (LSHTM) in partnership with the University of Manchester and University of Hull, initiated the 'Catch-up Screen'

Get Detailed Insights on the HPV Testing and PAP Test Market@

Ruta Halde
+ 32 498 86 80 79
Source: » Follow
Posted By:*** Email Verified
Location:Brussels - Brussels - Belgium
Account Email Address Verified     Account Phone Number Verified     Disclaimer     Report Abuse
Medi-tech Insights News
Most Viewed
Daily News

Like PRLog?
Click to Share